Körber Signs Agreement to Build Smart Factory
Körber and Immunotech Biopharm will implement Werum PAS-X MES in a greenfield cell and gene therapy facility in Beijing. This step represents a major milestone in launching Immunotech's digital transformation journey toward smart manufacturing.
As a leading company in cell and gene therapy in China, Immunotech views digitalization and smart manufacturing as core strategic pillars. By introducing Körber's Manufacturing Execution System (MES) Werum PAS-X in a greenfield facility in Beijing, Immunotech will build a new smart factory that ensures interconnectivity and data transfer throughout the entire production process while prioritizing safety and efficiency. In this way, the company can accelerate its strategic digitalization and intelligence process and deliver higher-quality products and services to market.
Dr. Wang Yu, Chief Executive Officer of Immunotech Biopharm Ltd, states: "We are very pleased to have reached a comprehensive partnership with Körber. The market-leading Werum PAS-X MES technology offers unique advantages that provide us with innovative benefits such as concepts and best practices in the industry.
PAS-X combines software, content and services and enables rapid deployment. We look forward eagerly to this joint collaboration, which provides a solid foundation for Immunotech to accelerate product commercialization and provide strong technical support in achieving our ultimate goal of helping patients."
Jerry Zheng, General Manager of Körber Business Area Pharma's China hub, adds: "Against the backdrop of Industry 4.0, the 'Made in China 2025' strategic plan and the integration of digitalization and intelligence across various industries in China represent the future trend of the pharmaceutical industry. Our PAS-X software solution has consistently focused on the factory and supply chain while also taking into account the specific requirements of regulatory authorities and the industry. MES is an important entry point and driver for smart manufacturing and a critical tool for pharmaceutical companies' digital transformation."
